- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00006786
Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer
Phase II Trial of Fluorouracil (5-FU), Leucovorin (LV), Irinotecan (CPT-11) and Bevacizumab (Anti-VEGF) in Previously Untreated Patients With Advanced Colorectal Cancer
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Bevacizumab may stop the growth of colorectal cancer by stopping blood flow to the tumor.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus bevacizumab in treating patients who have advanced colorectal cancer.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
OBJECTIVES: I. Determine the progression-free survival at 7 months of patients with previously untreated advanced colorectal cancer treated with fluorouracil, leucovorin calcium, irinotecan, and bevacizumab. II. Determine the response rate and overall survival of this patient population treated with this regimen. III. Determine the toxicity of this treatment regimen in these patients.
OUTLINE: This is a multicenter study. Patients receive irinotecan IV over 90 minutes, leucovorin calcium IV, and fluorouracil IV once weekly for 4 weeks. Patients also receive bevacizumab IV over 30-90 minutes once every 2 weeks. Treatment repeats every 6 weeks in the absence of disease progression or unacceptable toxicity. Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
PROJECTED ACCRUAL: A total of 75 patients will be accrued for this study within 1 year.
Undersøgelsestype
Fase
- Fase 2
Kontakter og lokationer
Studiesteder
-
-
Arizona
-
Scottsdale, Arizona, Forenede Stater, 85259-5404
- CCOP - Scottsdale Oncology Program
-
-
California
-
Duarte, California, Forenede Stater, 91010-3000
- Cancer Center and Beckman Research Institute, City of Hope
-
Palo Alto, California, Forenede Stater, 94304
- Veterans Affairs Medical Center - Palo Alto
-
Stanford, California, Forenede Stater, 94305-5408
- Stanford University Medical Center
-
-
Colorado
-
Denver, Colorado, Forenede Stater, 80209-5031
- CCOP - Colorado Cancer Research Program, Inc.
-
-
Delaware
-
Wilmington, Delaware, Forenede Stater, 19899
- CCOP - Christiana Care Health Services
-
-
District of Columbia
-
Washington, District of Columbia, Forenede Stater, 20307-5000
- Walter Reed Army Medical Center
-
Washington, District of Columbia, Forenede Stater, 20060
- MBCCOP-Howard University Cancer Center
-
-
Florida
-
Gainesville, Florida, Forenede Stater, 32608-1197
- Veterans Affairs Medical Center - Gainsville
-
Miami, Florida, Forenede Stater, 33125
- Veterans Affairs Medical Center - Miami
-
Tampa, Florida, Forenede Stater, 33612-9497
- H. Lee Moffitt Cancer Center and Research Institute
-
Tampa, Florida, Forenede Stater, 33612
- Veterans Affairs Medical Center - Tampa (Haley)
-
-
Georgia
-
Atlanta, Georgia, Forenede Stater, 30322
- Emory University Hospital - Atlanta
-
Decatur, Georgia, Forenede Stater, 30033
- Veterans Affairs Medical Center - Atlanta (Decatur)
-
-
Illinois
-
Chicago, Illinois, Forenede Stater, 60611-3013
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University
-
Chicago, Illinois, Forenede Stater, 60611
- Veterans Affairs Medical Center - Lakeside Chicago
-
Decatur, Illinois, Forenede Stater, 62526
- CCOP - Central Illinois
-
Evanston, Illinois, Forenede Stater, 60201
- CCOP - Evanston
-
Peoria, Illinois, Forenede Stater, 61602
- CCOP - Illinois Oncology Research Association
-
Urbana, Illinois, Forenede Stater, 61801
- CCOP - Carle Cancer Center
-
-
Indiana
-
Indianapolis, Indiana, Forenede Stater, 46202-5289
- Indiana University Cancer Center
-
Indianapolis, Indiana, Forenede Stater, 46202
- Veterans Affairs Medical Center - Indianapolis (Roudebush)
-
-
Iowa
-
Cedar Rapids, Iowa, Forenede Stater, 52403-1206
- CCOP - Cedar Rapids Oncology Project
-
Des Moines, Iowa, Forenede Stater, 50309-1016
- CCOP - Iowa Oncology Research Association
-
Iowa City, Iowa, Forenede Stater, 52242-1009
- Holden Comprehensive Cancer Center at the University of Iowa
-
-
Kansas
-
Wichita, Kansas, Forenede Stater, 67218
- Veterans Affairs Medical Center - Wichita
-
-
Louisiana
-
New Orleans, Louisiana, Forenede Stater, 70121
- CCOP - Ochsner
-
New Orleans, Louisiana, Forenede Stater, 70112
- MBCCOP - LSU Health Sciences Center
-
-
Maryland
-
Baltimore, Maryland, Forenede Stater, 21231-2410
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
-
-
Massachusetts
-
Boston, Massachusetts, Forenede Stater, 02215
- Beth Israel Deaconess Medical Center
-
Boston, Massachusetts, Forenede Stater, 02111
- New England Medical Center Hospital
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 48106
- CCOP - Ann Arbor Regional
-
Kalamazoo, Michigan, Forenede Stater, 49007-3731
- CCOP - Kalamazoo
-
-
Minnesota
-
Duluth, Minnesota, Forenede Stater, 55805
- CCOP - Duluth
-
Minneapolis, Minnesota, Forenede Stater, 55417
- Veterans Affairs Medical Center - Minneapolis
-
Minneapolis, Minnesota, Forenede Stater, 55455
- University of Minnesota Cancer Center
-
Rochester, Minnesota, Forenede Stater, 55905
- Mayo Clinic Cancer Center
-
Saint Louis Park, Minnesota, Forenede Stater, 55416
- CCOP - Metro-Minnesota
-
-
Nebraska
-
Omaha, Nebraska, Forenede Stater, 68131
- CCOP - Missouri Valley Cancer Consortium
-
Omaha, Nebraska, Forenede Stater, 68105
- Veterans Affairs Medical Center - Omaha
-
-
Nevada
-
Las Vegas, Nevada, Forenede Stater, 89106
- CCOP - Southern Nevada Cancer Research Foundation
-
-
New Jersey
-
East Orange, New Jersey, Forenede Stater, 07018-1095
- Veterans Affairs Medical Center - East Orange
-
Hackensack, New Jersey, Forenede Stater, 07601
- CCOP - Northern New Jersey
-
New Brunswick, New Jersey, Forenede Stater, 08901
- Cancer Institute Of New Jersey
-
-
New York
-
Albany, New York, Forenede Stater, 12208
- Veterans Affairs Medical Center - Albany
-
Bronx, New York, Forenede Stater, 10461
- Albert Einstein Comprehensive Cancer Center
-
Bronx, New York, Forenede Stater, 10466
- MBCCOP-Our Lady of Mercy Cancer Center
-
Brooklyn, New York, Forenede Stater, 11209
- Veterans Affairs Medical Center - Brooklyn
-
New York, New York, Forenede Stater, 10016
- NYU School of Medicine's Kaplan Comprehensive Cancer Center
-
New York, New York, Forenede Stater, 10010
- Veterans Affairs Medical Center - New York
-
Rochester, New York, Forenede Stater, 14642
- University of Rochester Cancer Center
-
-
North Dakota
-
Fargo, North Dakota, Forenede Stater, 58122
- CCOP - Merit Care Hospital
-
-
Ohio
-
Cleveland, Ohio, Forenede Stater, 44195
- Cleveland Clinic Taussig Cancer Center
-
Cleveland, Ohio, Forenede Stater, 44106-5065
- Ireland Cancer Center
-
Cleveland, Ohio, Forenede Stater, 44106
- Veterans Affairs Medical Center - Cleveland
-
Columbus, Ohio, Forenede Stater, 43206
- CCOP - Columbus
-
Toledo, Ohio, Forenede Stater, 43623-3456
- CCOP - Toledo Community Hospital Oncology Program
-
-
Oklahoma
-
Tulsa, Oklahoma, Forenede Stater, 74136
- CCOP - Sooner State
-
-
Pennsylvania
-
Danville, Pennsylvania, Forenede Stater, 17822-2001
- CCOP - Geisinger Clinic and Medical Center
-
Philadelphia, Pennsylvania, Forenede Stater, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Forenede Stater, 19102-1192
- Hahnemann University Hospital
-
Philadelphia, Pennsylvania, Forenede Stater, 19104-4283
- University of Pennsylvania Cancer Center
-
Philadelphia, Pennsylvania, Forenede Stater, 19104-9104
- University of Pennsylvania Health Systems
-
Pittsburgh, Pennsylvania, Forenede Stater, 15213-3489
- University of Pittsburgh Cancer Institute
-
Pittsburgh, Pennsylvania, Forenede Stater, 15240
- Veterans Affairs Medical Center - Pittsburgh
-
Wynnewood, Pennsylvania, Forenede Stater, 19096
- CCOP - MainLine Health
-
-
South Dakota
-
Sioux Falls, South Dakota, Forenede Stater, 57105-1080
- CCOP - Sioux Community Cancer Consortium
-
-
Tennessee
-
Nashville, Tennessee, Forenede Stater, 37232-6838
- Vanderbilt-Ingram Cancer Center
-
Nashville, Tennessee, Forenede Stater, 37212
- Veterans Affairs Medical Center - Nashville
-
-
Wisconsin
-
Madison, Wisconsin, Forenede Stater, 53792-6164
- University of Wisconsin Comprehensive Cancer Center
-
Madison, Wisconsin, Forenede Stater, 53705
- Veterans Affairs Medical Center - Madison
-
Marshfield, Wisconsin, Forenede Stater, 54449
- CCOP - Marshfield Medical Research and Education Foundation
-
Milwaukee, Wisconsin, Forenede Stater, 53226
- Medical College of Wisconsin
-
Milwaukee, Wisconsin, Forenede Stater, 53295
- Veterans Affairs Medical Center - Milwaukee (Zablocki)
-
-
-
-
-
San Juan, Puerto Rico, 00927-5800
- MBCCOP - San Juan
-
San Juan, Puerto Rico, 00927-5800
- Veterans Affairs Medical Center - San Juan
-
-
-
-
-
Pretoria, Sydafrika, 0001
- Pretoria Academic Hospitals
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
DISEASE CHARACTERISTICS: Histologically confirmed advanced or metastatic adenocarcinoma of the colon and rectum Surgically unresectable disease Measurable disease Disease outside the prior radiotherapy port and/or progressive disease within the previously irradiated volume
PATIENT CHARACTERISTICS: Age: 18 and over Performance status: ECOG 0-2 Life expectancy: Not specified Hematopoietic: WBC at least 3,000/mm3 Platelet count at least 100,000/mm3 No hemorrhagic events within the past 6 months Hepatic: Bilirubin normal SGOT normal INR no greater than 1.5 Renal: Creatinine no greater than 1.5 times upper limit of normal Cardiovascular: No thromboembolic events within the past 6 months Pulmonary: No evidence of pneumonia Other: No known hypersensitivity to recombinant humanized murine monoclonal antibodies No evidence of significant active infection (e.g., peritonitis or wound abscess) Not pregnant or nursing Negative pregnancy test Fertile patients must use effective contraception
PRIOR CONCURRENT THERAPY: Biologic therapy: No concurrent sargramostim (GM-CSF) Chemotherapy: At least 12 months since prior fluorouracil-based adjuvant chemotherapy No prior adjuvant irinotecan Endocrine therapy: Not specified Radiotherapy: See Disease Characteristics At least 2 weeks since prior radiotherapy and recovered Surgery: See Disease Characteristics Other: No prior therapy for advanced disease No concurrent therapeutic anticoagulation except for low-dose coumadin for maintenance of indwelling catheters
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
Samarbejdspartnere og efterforskere
Samarbejdspartnere
Efterforskere
- Studiestol: Bruce J. Giantonio, MD, Presbyterian Medical Center
Publikationer og nyttige links
Generelle publikationer
- Gray R, Giantonio BJ, O'Dwyer PJ, et al.: The safety of adding angiogenesis inhibition into treatment for colorectal, breast, and lung cancer: the Eastern Cooperative Oncology Group's (ECOG) experience with bevacizumab (anti-VEGF). [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-825, 2003.
- Giantonio BJ, Chen HX, Catalano PJ, et al.: Bowel perforation and fistula formation in colorectal cancer patients treated on Eastern Cooperative Oncology Group (ECOG) studies E2200 and E3200. [Abstract] J Clin Oncol 22 (Suppl 14): A-3017, 199s, 2004.
- Giantonio BJ, Levy DE, O'dwyer PJ, Meropol NJ, Catalano PJ, Benson AB 3rd; Eastern Cooperative Oncology Group. A phase II study of high-dose bevacizumab in combination with irinotecan, 5-fluorouracil, leucovorin, as initial therapy for advanced colorectal cancer: results from the Eastern Cooperative Oncology Group study E2200. Ann Oncol. 2006 Sep;17(9):1399-403. doi: 10.1093/annonc/mdl161. Epub 2006 Jul 27.
- Giantonio BJ, Levy D, O'Dwyer PJ, et al.: Bevacizumab (anti-VEGF) plus IFL (irinotecan, fluorouracil, leucovorin) as front-line therapy for advanced colorectal cancer (advCRC): results from the Eastern Cooperative Oncology Group (ECOG) Study E2200. [Abstract] Proceedings of the American Society of Clinical Oncology 22: A-1024, 2003.
- Giantonio BJ, Levy D, Catalano PJ, et al.: Incorporating angiogenesis inhibition with bevacizumab (anti-VEGF) into frontline chemotherapy with irinotecan (CPT-11), fluorouracil and leucovorin (FU/LV) for advanced colorectal cancer (advCRC): a toxicity analysis of ECOG study E2200. [Abstract] Proceedings of the American Society of Clinical Oncology 21: A-503, 2002.
Datoer for undersøgelser
Studer store datoer
Studiestart
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Sygdomme i fordøjelsessystemet
- Neoplasmer
- Neoplasmer efter sted
- Gastrointestinale neoplasmer
- Neoplasmer i fordøjelsessystemet
- Gastrointestinale sygdomme
- Tyktarmssygdomme
- Tarmsygdomme
- Intestinale neoplasmer
- Endetarmssygdomme
- Kolorektale neoplasmer
- Lægemidlers fysiologiske virkninger
- Molekylære mekanismer for farmakologisk virkning
- Enzymhæmmere
- Antimetabolitter, Antineoplastisk
- Antimetabolitter
- Antineoplastiske midler
- Immunsuppressive midler
- Immunologiske faktorer
- Beskyttelsesagenter
- Topoisomerasehæmmere
- Antineoplastiske midler, immunologiske
- Angiogenese-hæmmere
- Angiogenesemodulerende midler
- Vækststoffer
- Væksthæmmere
- Mikronæringsstoffer
- Vitaminer
- Calciumregulerende hormoner og midler
- Topoisomerase I-hæmmere
- Modgift
- Vitamin B kompleks
- Fluorouracil
- Bevacizumab
- Leucovorin
- Irinotecan
- Kalk
- Levoleucovorin
Andre undersøgelses-id-numre
- CDR0000068328
- ECOG-E2200
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Kolorektal cancer
-
University of ArkansasRekrutteringColorectal cancer og inflammatorisk tarmsygdomForenede Stater
-
University Health Network, TorontoAstraZenecaAktiv, ikke rekrutterendeAdenocarcinom i bugspytkirtlen | Leiomyosarkom | Mismatch Reparation Proficient Colorectal CancerCanada
-
Stingray TherapeuticsRekrutteringRefractory Metastatic Microsatellite Stabil Colorectal Cancer (MSS-CRC)Forenede Stater
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaIkke rekrutterer endnuKolorektal kirurgi | Robotkirurgi | Colorectal cancer og inflammatorisk tarmsygdom
-
Tianjin Medical University Cancer Institute and...RekrutteringMSI-H Advanced Colorectal CancerKina
-
Bristol-Myers SquibbAfsluttetMikrosatellit stabil kolorektal cancer | Mismatch Reparation Proficient Colorectal Cancer | Mikrosatellit ustabil kolorektal cancer | Mismatch Reparation Manglende tyktarmskræftForenede Stater, Australien, Belgien, Canada, Irland, Italien, Spanien, Frankrig
-
Syndax PharmaceuticalsMerck Sharp & Dohme LLCAfsluttetMelanom | Ikke-småcellet lungekræft | Mismatch Reparation-Proficient Colorectal CancerForenede Stater
Kliniske forsøg med fluorouracil
-
Guangdong Provincial People's HospitalShanghai Henlius BiotechAktiv, ikke rekrutterende
-
Combined Military Hospital (CMH) institute of Medical...Rekruttering
-
Washington University School of MedicineThe Joseph Sanchez FoundationRekrutteringPlanocellulært karcinom i hoved og hals | Tilbagevendende planocellulært karcinom i hoved og hals | Metastatisk planocellulært karcinomForenede Stater
-
M.D. Anderson Cancer CenterRekrutteringFlere aktiniske keratoserForenede Stater
-
Northern Jiangsu People's HospitalRekruttering
-
Instituto de Oftalmología Fundación Conde de ValencianaRekruttering
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityRekruttering
-
Sun Yat-sen UniversityUkendt
-
CStone PharmaceuticalsAktiv, ikke rekrutterendeIkke-operabelt lokalt avanceret, tilbagevendende eller metastatisk spiserørspladecellecarcinomKina
-
Sun Yat-sen UniversityZhejiang Cancer Hospital; Fudan University; Peking University Cancer Hospital... og andre samarbejdspartnereUkendtNasopharyngealt karcinomKina